Hal Mintz’s Sabby Capital disclosed a 1.5 million share position in Alliqua Biomedical Inc. (ALQA) last week. Sabby Capital held 665 thousand shares of ALQA at the end of 2015. Alliqua Biomedical is a tiny stock, yet several hedge funds have large positions in the stock. Perceptive Advisors, which returned 50% in 2015, owned 1.92 million shares at the end of 2015. James Flynn’s Deerfield Management also had a similar position, holding 1.88 million shares.